Steroid-Responsive Idiopathic Pulmonary Hemosiderosis in Adulthood: A Case Report.
DOI:
https://doi.org/10.51168/sjhrafrica.v7i2.2693Keywords:
Idiopathic pulmonary hemosiderosis, diffuse alveolar hemorrhage, hemoptysis, corticosteroids, case reportAbstract
Background:
Idiopathic pulmonary hemosiderosis (IPH) is a rare cause of diffuse alveolar hemorrhage (DAH), most commonly reported in children but occasionally seen in adults.
Case Presentation:
We describe a 30-year-old woman with recurrent hemoptysis, anemia, and dyspnea for two years. Investigations revealed iron deficiency anemia, diffuse ground-glass opacities on HRCT, and hemosiderin-laden macrophages on bronchoalveolar lavage. Transbronchial biopsy confirmed pulmonary hemosiderosis. She was treated with oral corticosteroids (0.75 mg/kg/day), resulting in complete clinical and radiological resolution within one month.
Conclusion:
This case highlights the importance of considering IPH in adults presenting with unexplained DAH and anemia, particularly in tuberculosis-endemic regions. Early recognition and corticosteroid therapy can lead to favorable outcomes.
References
Butt A, Ahmed R, Sheikh MDA, Khan O, Iqbal N, Rahman AJ, Khan JA. Idiopathic pulmonary hemosiderosis - A rare cause of chronic anemia. Monaldi Arch Chest Dis. 2020;90(2). https://doi.org/10.4081/monaldi.2020.1267
Saha BK, Milman N. Liposteroid therapy for idiopathic pulmonary hemosiderosis: A scoping review of the literature. Prague Med Rep. 2022;123(2):65. https://doi.org/10.14712/23362936.2022.6
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Dr. Krishnan Namboothiri E, Dr. Deependra Kumar Rai, Dr. Somesh Thakur, Dr. Javeeria Shabbir, Dr. Jisha G. Panicker, Dr. Sheetal Verma, Dr. Thaodem Collin

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.













